SOPHiA GENETICS SA — Company profile
Healthcare · Health Information Services · Switzerland
Last price 7.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 678.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom and a collaboration with AstraZeneca to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Details
| Name | SOPHiA GENETICS SA |
| Sector | Healthcare |
| Industry | Health Information Services |
| Employees | 415 |
| Founded | 2011 |
| Ipo Date | 2021-07-23 |
| Ceo | Ross Muken |
| Country | Switzerland |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | CH1125843347 |
| Cusip | H82027105 |
| Cik | 1840706 |
| Sic | 7374 |
Key executives
| Name | Title |
|---|---|
| Ross Jordan Muken B.Sc. | Chief Executive Officer and Director |
| Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder and Executive Chairman |
| George A. Cardoza M.B.A. | Executive Vice President and Chief Financial Officer |
| Abhimanyu Verma | Executive Vice President and Chief Technology Officer |
| Dr. Zhenyu Xu Ph.D. | Executive Vice President and Chief Scientific Officer |
| Kellen Sanger | Head of Strategy and Investor Relations |
| Daan van Well L.L.M., M.B.A. | Executive Vice President and Chief Legal and Compliance Officer |
| Kevin Puylaert | SVice President and Chief Sales Officer |
| Manuela Da Silva Valente B.A. | Executive Vice President and Chief People Officer |
| Dr. Philippe Menu M.B.A., M.D., Ph.D. | Executive Vice President, Chief Medical Officer and Chief Product Officer |
Contact
| Address | La PiEce 12, Rolle, 1180, Switzerland |
| Phone | 41 21 694 10 60 |
| Website | https://www.sophiagenetics.com |